in vivo CART– tag –
-
Why Is CAR-T So Expensive? Reading 3 Cost Drivers in Manufacturing & Access — and the Future Reshaped by Next-Gen Tech | Frontier of Therapy Series | CAR-T A6 [Beginner]
CAR-T therapy is one of the cancer treatments that has attracted particularly strong expectations in recent years. CAR-T therapy is one of the cancer treatments that has attracted particularly strong expectations in recent years. In fact... -
Where In Vivo CAR’s Hardest Problems Live: 4 Implementation Axes — Delivery, Control, Safety, CMC/Reg | Frontier of Therapy Series | CAR-T B5 [Expert]
If you want the beginner version first:→ A5: What is in vivo CAR? If you want the beginner version first:→ A5: What is in vivo CAR? “Making CAR cells inside the body” explained simply What you will learn Executive summary1) Delivery: the... -
What Is In Vivo CAR? Reading the Next-Gen Approach of Making CAR Cells Inside the Body Through 3 Mechanisms | Frontier of Therapy Series | CAR-T A5 [Beginner]
Prefer the beginner overview first?→ A0: What is CAR-T therapy? The big picture + index→ A4: Why CAR-T Is Expanding Beyond Cancer (Autoimmunity as an Prefer the beginner overview first?→ A0: What is CAR-T therapy? The big picture + index... -
Big Pharma Mega Deals in the Last Few Months Series Part 2 | Next-Generation Oncology: in vivo CAR-T, ADCs, Bispecifics and Oral Biologics
Among the many big pharma transactions announced in the last few months, oncology stands out as the area where activity is both dense and conceptually rich. Among the many big pharma transactions announced in the last few months, oncolog... -
News Watch: in vivo CAR-T RACE (2025 Global Update)
Last updated: 2025-09-01 JST What you will learn Three-Line SummaryWhy in vivo (now)?Company Highlights (Q3 2025)Two Paths, One GoalClinical KPIs to Watch Lead: The shift from ex vivo to in vivo CAR-T is turning into a full-blown race. B... -
Summer Beginner Series Grand Summary Part 1｜Anti-Obesity Drugs, ADCs, and In vivo CAR-T — From Beginner to Intermediate Insights
This article is the first half of the Morningglorysciences Summer Beginner Series Grand Summary. This article is the first half of the Morningglorysciences Summer Beginner Series Grand Summary. We revisit three major therapeutic modaliti... -
Summer Special Beginner Series Summary｜In vivo CAR-T: Evolution and Future of Cellular Immunotherapy
This article is the comprehensive summary of our Morningglorysciences Summer Beginner Series on “In vivo CAR-T.” Previous articles covered the basics, This article is the comprehensive summary of our Morningglorysciences Summer Beginner ... -
Beginner-Friendly in vivo CAR-T Series | Part 8
Global Strategies Shaping the Future of in vivo CAR-T Development Throughout this series, we have explored the cutting-edge developments of in vivo CAR-T therapy in an accessible way for beginners. Throughout this series, we have explore... -
Beginner-Friendly in vivo CAR-T Series｜Part 7
Key Figures Shaping the Future of in vivo CAR-T This series aims to provide a clear and accessible overview of the latest advancements in in vivo CAR-T therapies, especially for beginners. This series aims to provide a clear and accessib... -
In vivo CAR-T’s Convergence Phase: 4 Emerging Technologies That Could Reshape Cell Therapy
In vivo CAR-T therapy has rapidly emerged as a promising next-generation cancer treatment. In vivo CAR-T therapy has rapidly emerged as a promising next-generation cancer treatment. However, realizing its full potential requires overcomi... -
In vivo CAR-T’s First Wave of Clinical Trials: Reading the Players, Targets, and Frontiers
In previous installments, we've explored the fundamentals of CAR-T, the features of the in vivo model, gene delivery strategies, target antigens, and intracellular signaling. In previous installments, we've explored the fundamentals of C... -
[Introductory In vivo CAR-T Series #3] Key to Precision and Safety: Designing Smart CAR Expression
In this third installment of our introductory series on in vivo CAR-T, we focus on a vital component for realizing safe and effective therapy: the design of CAR expression. In this third installment of our introductory series on in vivo ... -
【Introductory In vivo CAR-T Series #2】The Technologies Behind In Vivo CAR-T: mRNA, Vectors, and Promoters
In the first installment of our series, we introduced the revolutionary CAR-T cell therapy through the moving story of Emily Whitehead. In the first installment of our series, we introduced the revolutionary CAR-T cell therapy through th... -
[Introductory In Vivo CAR-T Series #1] The Miracle of Emily: What Is CAR-T Therapy?
CAR-T cell therapy has emerged as a groundbreaking treatment that specifically targets cancer cells. Among its forms, the “in vivo type” CAR-T—where the therapeutic process happens inside the body—is gaining attention as a next-generatio...
1